Use oral therapy when clinically appropriate
Reconstituted peptide storage guidelines universally recommend refrigeration, and room temperature exposure should be minimized to the time required for preparation and administration
This requires appropriate preservative systems and packaging that prevents light exposure and air ingress
Yang, S
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
Izadi, S., Anandakrishnan, R